Hanneke van der Wijngaart

Chapter 1 General introduction 9
Chapter 2 The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs 23
Chapter 3 Patients with Biallelic BRCA1/2 Inactivation Respond to Olaparib Treatment Across Histologic Tumor Types 55
Chapter 4 Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics 87
Chapter 5 Advancing wide implementation of precision oncology: A liquid nitrogen-free snap freezer preserves molecular profiles of biological samples 129
Chapter 6 Summarizing discussion and future perspectives 157
Chapter 7 Nederlandse samenvatting 177
Chapter 8 Appendices 187
Dankwoord 188
Curriculum vitae 195
List of publications 196

RkJQdWJsaXNoZXIy MTk4NDMw